These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2417055)
1. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy. Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055 [TBL] [Abstract][Full Text] [Related]
2. Use of 111In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice. Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE J Surg Oncol; 1985 Jun; 29(2):71-7. PubMed ID: 2417054 [TBL] [Abstract][Full Text] [Related]
3. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals. Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427 [TBL] [Abstract][Full Text] [Related]
4. Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC. Hou DY; Hamburger AW; Beach JL; Maruyama Y Cancer Invest; 1989; 7(6):543-50. PubMed ID: 2483533 [TBL] [Abstract][Full Text] [Related]
5. Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex. Hou DY; Maruyama Y J Surg Oncol; 1990 May; 44(1):5-9. PubMed ID: 1692949 [TBL] [Abstract][Full Text] [Related]
6. A new 111In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice. Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE J Surg Oncol; 1984 Mar; 25(3):168-75. PubMed ID: 6199622 [TBL] [Abstract][Full Text] [Related]
7. Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines. Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R Int J Radiat Biol; 1998 May; 73(5):565-70. PubMed ID: 9652815 [TBL] [Abstract][Full Text] [Related]
8. Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin. Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE Eur J Nucl Med; 1983; 8(12):535-40. PubMed ID: 6199207 [TBL] [Abstract][Full Text] [Related]
9. Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice. Jääskelä-Saari HA; Grénman R; Ramsay HA; Tarkkanen J; Paavonen T; Kairemo KJ Cancer Biother Radiopharm; 2005 Aug; 20(4):426-35. PubMed ID: 16114991 [TBL] [Abstract][Full Text] [Related]
10. A low pH 111In-bleomycin complex: a tracer for radiochemotherapy of head and neck cancer. Kairemo KJ; Ramsay H; Nikula TK; Hopsu EV; Taavitsainen MJ; Bondestam S; Hiltunen JV J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):135-9. PubMed ID: 7543289 [TBL] [Abstract][Full Text] [Related]
11. Squamous cell cancer cell lines: sensitivity to bleomycin and suitability for animal xenograft studies. Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R Acta Otolaryngol Suppl; 1997; 529():241-4. PubMed ID: 9288321 [TBL] [Abstract][Full Text] [Related]
12. Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex. Hou DY; Ordonez JV; Cross RJ; Ross DD; Maruyama Y J Surg Oncol; 1989 Feb; 40(2):73-8. PubMed ID: 2464720 [TBL] [Abstract][Full Text] [Related]
13. Chromosome aberrations of human small cell lung cancer induced by a new 111In-bleomycin complex. Hou DY; Maruyama Y; Drago JR J Surg Oncol; 1992 Dec; 51(4):236-42. PubMed ID: 1279317 [TBL] [Abstract][Full Text] [Related]
14. Distribution and stability of [111In]bleomycin and its fractions in tumor-bearing mice. Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE Int J Nucl Med Biol; 1984; 11(2):129-39. PubMed ID: 6207129 [TBL] [Abstract][Full Text] [Related]
15. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects. Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096 [TBL] [Abstract][Full Text] [Related]
16. 111In-labelled bleomycin complex for the differentiation of high- and low-grade gliomas. Korppi-Tommola T; Huhmar H; Aronen HJ; Penttilä P; Hiltunen J; Savolainen S; Kallio ME; Liewendahl K Nucl Med Commun; 1999 Feb; 20(2):145-52. PubMed ID: 10088163 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of 111In-labeled bleomycin in patients with brain tumors: compartmental vs. non-compartmental models. Ryynänen PM; Savolainen SE; Aronen HJ; Korppi-Tommola ET; Huhmar HM; Kallio ME; Hiltunen JV Ann Nucl Med; 1998 Dec; 12(6):313-21. PubMed ID: 9972368 [TBL] [Abstract][Full Text] [Related]
18. Distribution of 111In-bleomycin complex in small cell lung cancer cells by autoradiography. Hou DY; Maruyama Y J Surg Oncol; 1992 Feb; 49(2):93-7. PubMed ID: 1371176 [TBL] [Abstract][Full Text] [Related]
19. Biokinetics of indium-111-bleomycin complex in head and neck cancer--implementations for radiochemotherapy. Kairemo KJ; Ramsay HA; Paavonen TK; Jääskelä-Saari HA; Tagesson M; Ljunggren K; Strand SE Cancer Detect Prev; 1997; 21(1):83-90. PubMed ID: 9043768 [TBL] [Abstract][Full Text] [Related]
20. [A new treatment of malignant brain tumor -1: local injection of bleomycin (author's transl)]. Nakazawa S; Ohwaki K; Shimura T; Itoh Y; Yajima K No Shinkei Geka; 1981 Dec; 9(13):1487-93. PubMed ID: 6179006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]